TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/09/06	05 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/09/06	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/09/06	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/09/06	05 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/09/06	05 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/09/05	00 : 44	Business Wire	Teva Announces $400 Million Debt Tender Offer	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/25	22 : 29	Dow Jones News	EpiPen Shortage Hits Back-to-School Season	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/17	06 : 54	Dow Jones News	Antares Pharma Shares Rise After FDA Approves First Rival Generic EpiPen	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/16	21 : 06	Dow Jones News	Regeneron, Teva Report Positive Phase 3 Fasinumab Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/16	20 : 00	Business Wire	Teva & Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/16	20 : 00	PR Newswire (US)	Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of t...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/06	21 : 00	Business Wire	Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/03	22 : 39	Dow Jones News	Acorda Signs Settlement With Mylan on Generic Ampyra	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/03	02 : 16	Dow Jones News	Teva Pharmaceutical's Sales Slump 18%	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/08/02	20 : 00	Business Wire	Teva Reports Second Quarter 2018 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/07/26	03 : 36	Dow Jones News	Acorda Shares Fall as Court Denies Injunction Request in Patent Case -- Market Mover	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/07/17	21 : 30	Business Wire	Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/07/14	09 : 05	Dow Jones News	FDA Recalls Several Medicines That Contain Valsartan	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/07/11	21 : 00	Business Wire	Teva to Report Second Quarter 2018 Financial Results on August 2, 2018	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/07/09	23 : 47	Business Wire	Teva Announces Launch of a Generic Version of Uceris® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/06/29	06 : 06	Dow Jones News	ADRs End Higher	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/06/28	21 : 00	Business Wire	Teva to Present New Fremanezumab Data, Including Long-Term Data, at the American Headache Society’s 60th Annual Scientific ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/06/15	21 : 00	Business Wire	Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/23	21 : 00	Business Wire	Teva Confirms September PDUFA Date for Fremanezumab	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/19	06 : 10	Business Wire	CORRECTING & REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Epi...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/16	07 : 53	Dow Jones News	Florida and Texas Are Among Latest States to Sue Opioid Painkiller Companies	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/16	00 : 05	Business Wire	Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the J...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/12	06 : 28	Dow Jones News	FDA Rejects Perrigo's ProAir Generic, Drug Maker Says	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/10	22 : 21	PR Newswire (Canada)	Teva Canada annonce le lancement de l'émulsion ophtalmique Teva-Cyclosporine®, la première version générique de Restasis...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/10	02 : 28	Dow Jones News	Mylan May Be Gem in Rough Generic Sector	NYSE:TEVA	Teva Pharmaceutical Industries Ltd